GlassScriptPhysician profile
Syed Ahmad
NPI 1831414556
$2,316.97
in general payments reported to CMS, 2019-2025
15 companies · $1,035 in 2025
The $1,035 reported for 2025 was more than what 95% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $370 · 2024: $911 · 2025: $1,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,316.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $795.49 | 2024-2025 | Puraply Wound Matrix, Cygnus Dual, Apligraf |
| Smith+Nephew, INC. | $756.62 | 2023-2025 | Grafix Pl, Oasis, Stravix |
| Biotissue Holdings INC. | $174.77 | 2023-2025 | |
| Abbvie INC. | $125.00 | 2025 | |
| Ets Wound Care LLC | $119.47 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Convatec INC. | $111.22 | 2024-2025 | |
| Solventum Corporation | $89.00 | 2024 | Promogran Prisma, Kerramax Care, Activ.A.C. |
| Kerecis Limited | $25.04 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Hartmann USA, INC. | $23.92 | 2024 | Zetuvit Plus 10x10 P10 |
| Glaxosmithkline, LLC. | $20.02 | 2025 | Ojjaara |
| Melinta Therapeutics, LLC | $17.64 | 2025 | Rezzayo |
| Urgo Medical North America, LLC | $14.97 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Recordati_rare_diseases_inc. | $14.75 | 2025 | Sylvant |
| Mimedx Group, INC. | $14.66 | 2025 | |
| Kci USA, INC. | $14.40 | 2023 | 3m Coban, 3m Cavilon, Kerramax Care |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.